TERT and breast cancer: The beneficial effects of 5-FdU on metastatic breast cancer cells appear to be dependent upon telomerase, as evidenced by the loss of therapeutic efficacy after genetic ablation (Fig 6G and H) or pharmacologic inhibition (Fig S6A) of TERT.